NO20080219L - Fentanylformulering som inneholder en essensiell olje - Google Patents
Fentanylformulering som inneholder en essensiell oljeInfo
- Publication number
- NO20080219L NO20080219L NO20080219A NO20080219A NO20080219L NO 20080219 L NO20080219 L NO 20080219L NO 20080219 A NO20080219 A NO 20080219A NO 20080219 A NO20080219 A NO 20080219A NO 20080219 L NO20080219 L NO 20080219L
- Authority
- NO
- Norway
- Prior art keywords
- essential oil
- formulation containing
- fentanyl formulation
- fentanyl
- formulations
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- PJMPHNIQZUBGLI-UHFFFAOYSA-N fentanyl Chemical compound C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 PJMPHNIQZUBGLI-UHFFFAOYSA-N 0.000 title abstract 2
- 229960002428 fentanyl Drugs 0.000 title abstract 2
- 239000000341 volatile oil Substances 0.000 title 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract 3
- 239000007921 spray Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0514043.9A GB0514043D0 (en) | 2005-07-08 | 2005-07-08 | Fentanyl formulation |
| PCT/GB2006/002526 WO2007007059A1 (fr) | 2005-07-08 | 2006-07-07 | Formulation de fentanyle contenant une huile essentielle |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20080219L true NO20080219L (no) | 2008-02-05 |
Family
ID=34896944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20080219A NO20080219L (no) | 2005-07-08 | 2008-01-14 | Fentanylformulering som inneholder en essensiell olje |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1904032B1 (fr) |
| JP (1) | JP2009500387A (fr) |
| KR (1) | KR20080044232A (fr) |
| CN (1) | CN101247788A (fr) |
| AT (1) | ATE490762T1 (fr) |
| AU (1) | AU2006268052A1 (fr) |
| BR (1) | BRPI0612771A2 (fr) |
| CA (1) | CA2614420A1 (fr) |
| DE (1) | DE602006018738D1 (fr) |
| GB (1) | GB0514043D0 (fr) |
| IL (1) | IL188639A0 (fr) |
| MX (1) | MX2008000342A (fr) |
| NO (1) | NO20080219L (fr) |
| WO (1) | WO2007007059A1 (fr) |
| ZA (1) | ZA200800147B (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001281746C1 (en) | 2000-07-31 | 2010-09-09 | ISTITUTO GENTILI S.r.l. | Fentanyl composition for nasal administration |
| MX374396B (es) | 2006-01-25 | 2025-03-06 | Insys Therapeutics Inc | Rocio de fentanilo sublingual. |
| RS54764B1 (sr) | 2006-07-21 | 2016-10-31 | Biodelivery Sciences Int Inc | Sredstvo za transmukozalnu isporuku sa povećanim nakupljanjem |
| US8173666B2 (en) | 2007-03-12 | 2012-05-08 | Nektar Therapeutics | Oligomer-opioid agonist conjugates |
| US10512644B2 (en) | 2007-03-12 | 2019-12-24 | Inheris Pharmaceuticals, Inc. | Oligomer-opioid agonist conjugates |
| DK2180844T3 (en) * | 2007-08-02 | 2018-04-23 | Insys Dev Co Inc | SUBLINGUAL FENTANYLSPRAY |
| GB2476494A (en) * | 2009-12-24 | 2011-06-29 | Norwich Pharma Technologies Ltd | Formulation for the sublingual delivery of sufentanil |
| GB2481619B (en) * | 2010-06-30 | 2012-06-20 | Londonpharma Ltd | Formulations and delivery devices for the sublingual administration of opioids |
| US9901539B2 (en) | 2011-12-21 | 2018-02-27 | Biodelivery Sciences International, Inc. | Transmucosal drug delivery devices for use in chronic pain relief |
| GB2487007B (en) * | 2012-03-19 | 2013-06-05 | Londonpharma Ltd | COC containers and delivery devices for the sublingual administration of opioids |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2017916C (fr) * | 1989-06-07 | 1999-02-02 | Minoru Aoki | Preparations a base d'etoposide |
| JP2002037735A (ja) * | 2000-05-15 | 2002-02-06 | Rohto Pharmaceut Co Ltd | カフェイン類の安定化方法および粘膜適用組成物 |
| WO2001097780A2 (fr) * | 2000-06-22 | 2001-12-27 | Pharmasol Ltd | Compositions pharmaceutiques |
| JP2003171311A (ja) * | 2001-09-26 | 2003-06-20 | Lion Corp | 内服液剤組成物、それを含む内服液剤品 |
| EP1608372A2 (fr) | 2003-03-11 | 2005-12-28 | Arakis Ltd. | Compositions contenant du fentanyle |
-
2005
- 2005-07-08 GB GBGB0514043.9A patent/GB0514043D0/en not_active Ceased
-
2006
- 2006-07-07 BR BRPI0612771-1A patent/BRPI0612771A2/pt not_active IP Right Cessation
- 2006-07-07 DE DE602006018738T patent/DE602006018738D1/de active Active
- 2006-07-07 WO PCT/GB2006/002526 patent/WO2007007059A1/fr not_active Ceased
- 2006-07-07 JP JP2008520002A patent/JP2009500387A/ja active Pending
- 2006-07-07 KR KR1020087001190A patent/KR20080044232A/ko not_active Withdrawn
- 2006-07-07 ZA ZA200800147A patent/ZA200800147B/xx unknown
- 2006-07-07 MX MX2008000342A patent/MX2008000342A/es not_active Application Discontinuation
- 2006-07-07 CA CA002614420A patent/CA2614420A1/fr not_active Abandoned
- 2006-07-07 EP EP06755740A patent/EP1904032B1/fr not_active Not-in-force
- 2006-07-07 AU AU2006268052A patent/AU2006268052A1/en not_active Abandoned
- 2006-07-07 CN CNA2006800247135A patent/CN101247788A/zh active Pending
- 2006-07-07 AT AT06755740T patent/ATE490762T1/de not_active IP Right Cessation
-
2008
- 2008-01-07 IL IL188639A patent/IL188639A0/en unknown
- 2008-01-14 NO NO20080219A patent/NO20080219L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1904032A1 (fr) | 2008-04-02 |
| BRPI0612771A2 (pt) | 2010-11-30 |
| CN101247788A (zh) | 2008-08-20 |
| MX2008000342A (es) | 2008-04-02 |
| ZA200800147B (en) | 2009-07-29 |
| KR20080044232A (ko) | 2008-05-20 |
| AU2006268052A1 (en) | 2007-01-18 |
| EP1904032B1 (fr) | 2010-12-08 |
| CA2614420A1 (fr) | 2007-01-18 |
| DE602006018738D1 (de) | 2011-01-20 |
| GB0514043D0 (en) | 2005-08-17 |
| IL188639A0 (en) | 2008-04-13 |
| ATE490762T1 (de) | 2010-12-15 |
| WO2007007059A1 (fr) | 2007-01-18 |
| JP2009500387A (ja) | 2009-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20080219L (no) | Fentanylformulering som inneholder en essensiell olje | |
| AR095848A2 (es) | Derivados imidazolicos de propionamida moduladores de receptores opioides | |
| DK3984528T3 (da) | Farmaceutiske sammensætninger, som omfatter nilotinib | |
| EA200802008A1 (ru) | Фармацевтические композиции | |
| NO20081160L (no) | Benzimidazoltiofen forbindelser | |
| MX2009003934A (es) | Dosificador de dosis unitarias de detergente con componente que suministra fragancia. | |
| EA200701790A1 (ru) | Твёрдый фармацевтический дозированный состав | |
| ECSP11010812A (es) | Complejo de mineral-aminoácido polisacárido | |
| DK1594944T3 (da) | Rengöringssammensætninger i tabletform | |
| NO20090797L (no) | Farmasoytiske blandinger omfattende kandesartan cileksetil | |
| EA201270590A1 (ru) | Ингибиторы акт | |
| PA8792401A1 (es) | Fenilendiaminas | |
| UY30451A1 (es) | 18-metil-19-nor-androst-4-en-17,17-espiroéteres (18-metil-19-nor-20-espirox-4-en-3-onas),ase como preparaciones farmacéuticas que lo contienen. | |
| UA100850C2 (ru) | Средство для борьбы с паразитами на животных | |
| ATE537822T1 (de) | Antidepressivum | |
| SV2006002001A (es) | Inhibidores de quinasa ref. x - 16437 | |
| CL2012002543A1 (es) | Composicion endoparasiticida que comprende una combinacion de un compuesto de formula (i) derivado de amidoacetonitrilo y abamectina; y su uso para el control de endoparasitos, en particular helmintos. | |
| EA200501698A1 (ru) | Противовспенивающие композиции | |
| WO2008146883A1 (fr) | Agent d'amélioration du sommeil | |
| DK1749001T3 (da) | 3-piperidinylisochroman-5-ol som dopaminagonister | |
| DK1931636T3 (da) | Isoquinoliner som IGF-1R-inhibitorer | |
| CR11628A (es) | ASOCIACION DE UN INHIBIDOR DE CORRIENTE SINUSUAL If Y DE UN BETA-BLOQUEANTE | |
| MXPA05009602A (es) | Composiciones novedosas. | |
| EA200870236A1 (ru) | Моногидрат римонабанта, способ его получения и фармацевтические композиции на его основе | |
| MX380998B (es) | Combinacion farmaceutica de opioide y compuesto de prostaglandina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |